Q32 Bio Inc.QTTBNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-31.12%
↓ 1026% below average
Average (32q)
3.36%
Historical baseline
Range
High:93.59%
Low:-70.86%
Volatility
4893.9%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -31.12% |
| Q2 2025 | -27.55% |
| Q1 2025 | -32.44% |
| Q4 2024 | -26.50% |
| Q3 2024 | 6.97% |
| Q2 2024 | 36.28% |
| Q1 2024 | 18.01% |
| Q4 2023 | 11.74% |
| Q3 2023 | -6.91% |
| Q2 2023 | 1.35% |
| Q1 2023 | -70.86% |
| Q4 2022 | 5.01% |
| Q3 2022 | 22.68% |
| Q2 2022 | -13.18% |
| Q1 2022 | 2.65% |
| Q4 2021 | -1.42% |
| Q3 2021 | 1.22% |
| Q2 2021 | 8.93% |
| Q1 2021 | -6.21% |
| Q4 2020 | 13.61% |
| Q3 2020 | -25.68% |
| Q2 2020 | -6.27% |
| Q1 2020 | 44.09% |
| Q4 2019 | -20.82% |
| Q3 2019 | 12.55% |
| Q2 2019 | 11.16% |
| Q1 2019 | 26.13% |
| Q4 2018 | 21.56% |
| Q3 2018 | 30.16% |
| Q2 2018 | 28.66% |
| Q1 2018 | -16.49% |
| Q4 2017 | 93.59% |
| Q3 2017 | 0.00% |